1.43
전일 마감가:
$1.49
열려 있는:
$1.5
하루 거래량:
986.92K
Relative Volume:
0.89
시가총액:
$87.79M
수익:
$5.03M
순이익/손실:
$-185.41M
주가수익비율:
-0.4628
EPS:
-3.09
순현금흐름:
$-139.79M
1주 성능:
-10.06%
1개월 성능:
-2.72%
6개월 성능:
-11.73%
1년 성능:
-88.67%
Pliant Therapeutics Inc Stock (PLRX) Company Profile
명칭
Pliant Therapeutics Inc
전화
650-481-6770
주소
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
PLRX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PLRX
Pliant Therapeutics Inc
|
1.43 | 91.47M | 5.03M | -185.41M | -139.79M | -3.09 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-04 | 재개 | Cantor Fitzgerald | Neutral |
2025-03-04 | 다운그레이드 | Needham | Buy → Hold |
2025-03-03 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
2025-03-03 | 다운그레이드 | Stifel | Buy → Hold |
2025-02-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2025-02-10 | 다운그레이드 | Citigroup | Buy → Neutral |
2025-02-10 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2025-02-10 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2025-02-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2025-02-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2025-02-10 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2024-09-09 | 재개 | Leerink Partners | Outperform |
2023-12-08 | 개시 | Wells Fargo | Overweight |
2023-05-18 | 개시 | Canaccord Genuity | Buy |
2023-04-13 | 개시 | Robert W. Baird | Outperform |
2022-12-14 | 개시 | Stifel | Buy |
2022-12-07 | 개시 | JP Morgan | Overweight |
2022-09-01 | 개시 | Citigroup | Buy |
2022-07-20 | 개시 | SVB Leerink | Outperform |
2022-05-25 | 개시 | Cantor Fitzgerald | Overweight |
2021-12-10 | 개시 | Oppenheimer | Outperform |
2021-11-24 | 개시 | RBC Capital Mkts | Outperform |
2021-11-03 | 개시 | H.C. Wainwright | Buy |
2021-04-20 | 개시 | BTIG Research | Buy |
2021-04-05 | 개시 | Citigroup | Buy |
2020-06-29 | 개시 | Citigroup | Buy |
2020-06-29 | 개시 | Cowen | Outperform |
2020-06-29 | 개시 | Needham | Buy |
2020-06-29 | 개시 | Piper Sandler | Overweight |
모두보기
Pliant Therapeutics Inc 주식(PLRX)의 최신 뉴스
Guidance Update: Can Lexicon Pharmaceuticals Inc. reach all time highs this yearMarket Performance Summary & Daily Technical Forecast Reports - khodrobank.com
Acadian Asset Management LLC Invests $1.64 Million in Pliant Therapeutics, Inc. $PLRX - MarketBeat
Aug Final Week: What are Pliant Therapeutics Incs technical support levelsJuly 2025 Sector Moves & Verified Chart Pattern Signals - khodrobank.com
Growth Recap: Is Pliant Therapeutics Inc. still a buy after recent gainsEarnings Overview Report & Free Weekly Chart Analysis and Trade Guides - khodrobank.com
Aug Closing: What analysts say about Pliant Therapeutics Inc stockMarket Growth Review & Growth Oriented Trading Recommendations - khodrobank.com
Aug Catalysts: Can Alamos Gold Inc sustain its profitabilityJuly 2025 Short Interest & High Return Trade Guides - خودرو بانک
Technical Analysis: Can Pliant Therapeutics Inc sustain earnings growth2025 Performance Recap & Long-Term Investment Growth Plans - khodrobank.com
Market Leaders: How do insiders feel about ECB Bancorp IncPortfolio Return Summary & Safe Capital Growth Trade Ideas - خودرو بانک
Aug Reactions: Is Pliant Therapeutics Inc benefiting from interest rate changesJuly 2025 Gainers & Low Volatility Stock Recommendations - khodrobank.com
Market Leaders: How liquid is Pliant Therapeutics Inc stock2025 Volume Leaders & Reliable Price Breakout Signals - khodrobank.com
Risks Report: Why is Pliant Therapeutics Inc stock going upPortfolio Return Summary & AI Powered Buy and Sell Recommendations - khodrobank.com
Fundamentals Check: Is Pliant Therapeutics Inc likely to announce a buybackCPI Data & Daily Momentum Trading Reports - khodrobank.com
Aug Sentiment: Is Pliant Therapeutics Inc still a buy after recent gains2025 Market Trends & Fast Gaining Stock Strategy Reports - khodrobank.com
VIX Spike: Can Pliant Therapeutics Inc sustain earnings growthEarnings Recap Report & Risk Managed Trade Strategies - khodrobank.com
Aug Momentum: Will Pliant Therapeutics Inc. announce a stock split2025 Analyst Calls & Risk Controlled Daily Plans - khodrobank.com
Will Pliant Therapeutics Inc. stock outperform tech sector in 2025July 2025 Outlook & AI Forecasted Stock Moves - baoquankhu1.vn
Nuveen LLC Acquires New Stake in Pliant Therapeutics, Inc. $PLRX - MarketBeat
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz - RTTNews
Is Pliant Therapeutics Inc. benefiting from interest rate changesGDP Growth & Stock Market Timing Techniques - Lancaster City Council
Cormorant Asset Management LP Invests $4.05 Million in Pliant Therapeutics, Inc. $PLRX - MarketBeat
Can Pliant Therapeutics Inc. navigate macro headwindsMarket Volume Summary & Proven Capital Preservation Tips - beatles.ru
Penny Stocks To Watch With Market Caps Under $700M - simplywall.st
Is Pliant Therapeutics Inc. stock risky to hold nowPortfolio Value Summary & Daily Profit Maximizing Tips - beatles.ru
Redmile Group LLC Reduces Stock Holdings in Pliant Therapeutics, Inc. $PLRX - MarketBeat
Pliant Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - Newser
What’s next for Pliant Therapeutics Inc. stock priceAnalyst Upgrade & Community Verified Watchlist Alerts - Newser
What analysts say about Pliant Therapeutics Inc. stockWeekly Trend Report & Free Long-Term Investment Growth Plans - خودرو بانک
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Receives $8.19 Average PT from Analysts - MarketBeat
Sector ETF performance correlation with Pliant Therapeutics Inc.Weekly Profit Report & AI Based Buy and Sell Signals - Newser
Is Pliant Therapeutics Inc. stock entering bullish territoryPrice Action & Verified High Yield Trade Plans - Newser
Pliant Therapeutics Inc. stock volume spike explainedGap Up & Free Expert Approved Momentum Trade Ideas - Newser
What’s the profit margin of Pliant Therapeutics Inc.2025 Price Momentum & Trade Opportunity Analysis - خودرو بانک
Strategies to average down on Pliant Therapeutics Inc.2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
Institutional scanner results for Pliant Therapeutics Inc.2025 Dividend Review & Long-Term Growth Portfolio Plans - Newser
Published on: 2025-09-05 06:24:37 - Newser
Why Pliant Therapeutics Inc. is moving todayJuly 2025 Catalysts & Long-Term Capital Growth Strategies - Newser
Live market analysis of Pliant Therapeutics Inc.Index Update & Free Low Drawdown Momentum Trade Ideas - Newser
How to build a custom watchlist for Pliant Therapeutics Inc.2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Is Pliant Therapeutics Inc. forming a bottoming base2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Analyzing drawdowns of Pliant Therapeutics Inc. with statistical toolsJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
Relative strength of Pliant Therapeutics Inc. in sector analysis2025 Support & Resistance & Daily Oversold Bounce Ideas - Newser
Does Pliant Therapeutics Inc. stock have upside surprise potentialJuly 2025 PostEarnings & Weekly Breakout Watchlists - خودرو بانک
How cyclical is Pliant Therapeutics Inc.’s revenue stream2025 Retail Activity & Capital Efficiency Focused Ideas - خودرو بانک
Pliant Therapeutics Inc. stock trendline breakdownWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
Live market analysis of Pliant Therapeutics IncJuly 2025 Big Picture & Technical Pattern Recognition Alerts - Newser
What Fibonacci levels say about Pliant Therapeutics Inc. rebound2025 Short Interest & Long-Term Growth Portfolio Plans - Newser
Will Pliant Therapeutics Inc. stock split in the near future2025 Top Decliners & AI Powered Trade Plan Recommendations - Newser
How to use Fibonacci retracement on Pliant Therapeutics Inc.New Guidance & Free Technical Pattern Based Buy Signals - Newser
How to forecast Pliant Therapeutics Inc. trends using time seriesMarket Weekly Review & Momentum Based Trading Ideas - Newser
Is Pliant Therapeutics Inc. meeting your algorithmic filter criteria2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Sentiment analysis tools applied to Pliant Therapeutics Inc.2025 Technical Patterns & Free Community Supported Trade Ideas - Newser
Pliant Therapeutics Inc (PLRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pliant Therapeutics Inc 주식 (PLRX) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Cummings Keith Lamont | Chief Financial Officer |
Jan 17 '25 |
Sale |
11.20 |
20,148 |
225,680 |
262,608 |
Hull Hans | Chief Business Officer |
Jan 17 '25 |
Sale |
11.20 |
15,936 |
178,501 |
211,558 |
Lefebvre Eric | Chief Medical Officer |
Jan 17 '25 |
Sale |
11.20 |
18,478 |
206,974 |
194,574 |
Cheung Lily | Chief Human Resource Officer |
Jan 17 '25 |
Sale |
11.20 |
3,740 |
41,892 |
24,550 |
Ouimette Mike | General Counsel & Corp. Sec'y |
Jan 17 '25 |
Sale |
11.20 |
13,270 |
148,639 |
80,774 |
Ouimette Mike | General Counsel & Corp. Sec'y |
Jan 22 '25 |
Sale |
10.99 |
10,230 |
112,462 |
70,544 |
자본화:
|
볼륨(24시간):